These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23847733)

  • 1. Integrated fluorescence correlation spectroscopy device for point-of-care clinical applications.
    Olson E; Torres R; Levene MJ
    Biomed Opt Express; 2013 Jul; 4(7):1074-82. PubMed ID: 23847733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical measurement of von Willebrand factor by fluorescence correlation spectroscopy.
    Torres R; Genzen JR; Levene MJ
    Clin Chem; 2012 Jun; 58(6):1010-8. PubMed ID: 22451621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Fluorescence Cross-Correlation-Spectroscopy-Based Immunoassay for Rapid, Selective, and Accurate Protein Sizing in Human Plasma, Applied to the von Willebrand Factor.
    Ganguly AK; Ramaswamy L; Watanabe S; Ide N; Kinjo M; Harada A
    Anal Chem; 2023 May; 95(21):8172-8179. PubMed ID: 37198563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue dynamics of von Willebrand factor characterized by a novel fluorescent protein-von Willebrand factor chimera.
    Xu L; Qiu Y; Li Y; Wei Y; Wan Y; Deng W
    J Thromb Haemost; 2022 Jan; 20(1):208-221. PubMed ID: 34592034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical approaches promote advances in the understanding of von Willebrand factor processing and function.
    Löf A; Müller JP; Benoit M; Brehm MA
    Adv Biol Regul; 2017 Jan; 63():81-91. PubMed ID: 27717713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing a method for in vitro investigation of mechanical parameters causing acquired von Willebrand syndrome in ventricular assist devices.
    Egger C; Maas J; Hufen T; Schmitz-Rode T; Steinseifer U
    Artif Organs; 2013 Sep; 37(9):833-9. PubMed ID: 23834027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exponential size distribution of von Willebrand factor.
    Lippok S; Obser T; Müller JP; Stierle VK; Benoit M; Budde U; Schneppenheim R; Rädler JO
    Biophys J; 2013 Sep; 105(5):1208-16. PubMed ID: 24010664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fiber-optic fluorescence correlation spectrometer.
    Garai K; Muralidhar M; Maiti S
    Appl Opt; 2006 Oct; 45(28):7538-42. PubMed ID: 16983444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of von Willebrand factor profiles after implantation of left ventricular assist device and total artificial heart.
    Reich HJ; Morgan J; Arabia F; Czer L; Moriguchi J; Ramzy D; Esmailian F; Lam L; Dunhill J; Volod O
    J Thromb Haemost; 2017 Aug; 15(8):1620-1624. PubMed ID: 28586149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of acquired von Willebrand syndrome after ventricular assist device by total thrombus-formation analysis system.
    Takashio S; Kaikita K; Nishi M; Morioka M; Higo T; Shiose A; Doman T; Horiuchi H; Fukui T; Tsujita K
    ESC Heart Fail; 2020 Oct; 7(5):3235-3239. PubMed ID: 32700467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of a semi-automated and rapid commercial electrophoresis assay for von Willebrand factor multimers.
    Pikta M; Zemtsovskaja G; Bautista H; Nouadje G; Szanto T; Viigimaa M; Banys V
    J Clin Lab Anal; 2018 Jul; 32(6):e22416. PubMed ID: 29453814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD management.
    Bartoli CR; Kang J; Motomura T
    J Card Surg; 2020 Jul; 35(7):1477-1483. PubMed ID: 32652785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization.
    Casonato A; Pontara E; Sartorello F; Bertomoro A; Durante C; Girolami A
    J Lab Clin Med; 2001 Jan; 137(1):70-6. PubMed ID: 11150026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of a dominant-negative von Willebrand factor multimerization defect by small interfering RNA-mediated allele-specific inhibition of mutant von Willebrand factor.
    de Jong A; Dirven RJ; Oud JA; Tio D; van Vlijmen BJM; Eikenboom J
    J Thromb Haemost; 2018 Jul; 16(7):1357-1368. PubMed ID: 29734512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shear-Induced Unfolding and Enzymatic Cleavage of Full-Length VWF Multimers.
    Lippok S; Radtke M; Obser T; Kleemeier L; Schneppenheim R; Budde U; Netz RR; Rädler JO
    Biophys J; 2016 Feb; 110(3):545-554. PubMed ID: 26840720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test.
    Mori F; Rossi P; Nardini I; Gambelli D; Farina C
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):221-8. PubMed ID: 20179578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High and long-term von Willebrand factor expression after Sleeping Beauty transposon-mediated gene therapy in a mouse model of severe von Willebrand disease.
    Portier I; Vanhoorelbeke K; Verhenne S; Pareyn I; Vandeputte N; Deckmyn H; Goldenberg DS; Samal HB; Singh M; Ivics Z; Izsvák Z; De Meyer SF
    J Thromb Haemost; 2018 Mar; 16(3):592-604. PubMed ID: 29288565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Note: An easy way to enable total internal reflection-fluorescence correlation spectroscopy (TIR-FCS) by combining commercial devices for FCS and TIR microscopy.
    Yordanov S; Best A; Weisshart K; Koynov K
    Rev Sci Instrum; 2011 Mar; 82(3):036105. PubMed ID: 21456807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyphosphate binds to human von Willebrand factor in vivo and modulates its interaction with glycoprotein Ib.
    Montilla M; Hernández-Ruiz L; García-Cozar FJ; Alvarez-Laderas I; Rodríguez-Martorell J; Ruiz FA
    J Thromb Haemost; 2012 Nov; 10(11):2315-23. PubMed ID: 23006049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory Testing for von Willebrand Disease Using a Composite Rapid 3-Test Chemiluminescence-Based von Willebrand Factor Assay Panel.
    Favaloro EJ; Mohammed S; Vong R; Pasalic L
    Methods Mol Biol; 2023; 2663():647-667. PubMed ID: 37204743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.